CFTR Biomarkers, Canada
Objective: The purpose is to identify promising novel candidate plasma and nasal cell biomarkers that indicate responsiveness to CF Modulator therapy in cystic fibrosis adult patients. Using a non-targeted approach, we will identify proteins to discover novel candidate plasma biomarkers that change in levels of expression from untreated to treated state, as well as comparing to healthy controls. The purpose of the optional genetics study is to discover new information from RNA in the blood that indicate CF modulator therapy response in CF patients. We will focus on the RNA molecules that change in levels between treated and untreated states.
|Registered Biobank Name||CFTR Biomarkers|
|Biobank Leader||Genevieve Rocheleau|
|Email for biobank inquiries||Bradley.email@example.com|
|Principal Investigator||Bradley Quon|